161 related articles for article (PubMed ID: 37974462)
21. Attention-based GCN integrates multi-omics data for breast cancer subtype classification and patient-specific gene marker identification.
Guo H; Lv X; Li Y; Li M
Brief Funct Genomics; 2023 Nov; 22(5):463-474. PubMed ID: 37114942
[TBL] [Abstract][Full Text] [Related]
22. Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J; Salari K; Bocanegra M; Choi YL; Girard L; Gandhi J; Kwei KA; Hernandez-Boussard T; Wang P; Gazdar AF; Minna JD; Pollack JR
PLoS One; 2009 Jul; 4(7):e6146. PubMed ID: 19582160
[TBL] [Abstract][Full Text] [Related]
23. The gene expression landscape of breast cancer is shaped by tumor protein p53 status and epithelial-mesenchymal transition.
Fredlund E; Staaf J; Rantala JK; Kallioniemi O; Borg A; Ringnér M
Breast Cancer Res; 2012 Jul; 14(4):R113. PubMed ID: 22839103
[TBL] [Abstract][Full Text] [Related]
24. Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.
Gatza ML; Kung HN; Blackwell KL; Dewhirst MW; Marks JR; Chi JT
Breast Cancer Res; 2011 Jun; 13(3):R62. PubMed ID: 21672245
[TBL] [Abstract][Full Text] [Related]
25. ioSearch: An approach for identifying interacting multiomics biomarkers using a novel algorithm with application on breast cancer data sets.
Das S; Srivastava DK
Genet Epidemiol; 2023 Dec; 47(8):600-616. PubMed ID: 37795815
[TBL] [Abstract][Full Text] [Related]
26. Basal-like breast cancer cells induce phenotypic and genomic changes in macrophages.
Stewart DA; Yang Y; Makowski L; Troester MA
Mol Cancer Res; 2012 Jun; 10(6):727-38. PubMed ID: 22532586
[TBL] [Abstract][Full Text] [Related]
27. Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis.
Natrajan R; Sailem H; Mardakheh FK; Arias Garcia M; Tape CJ; Dowsett M; Bakal C; Yuan Y
PLoS Med; 2016 Feb; 13(2):e1001961. PubMed ID: 26881778
[TBL] [Abstract][Full Text] [Related]
28. Epigenomic and Transcriptomic Characterization of Secondary Breast Cancers.
Graff-Baker AN; Orozco JIJ; Marzese DM; Salomon MP; Hoon DSB; Goldfarb M
Ann Surg Oncol; 2018 Oct; 25(10):3082-3087. PubMed ID: 29956094
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping.
Sathyanarayanan A; Gupta R; Thompson EW; Nyholt DR; Bauer DC; Nagaraj SH
Brief Bioinform; 2020 Dec; 21(6):1920-1936. PubMed ID: 31774481
[TBL] [Abstract][Full Text] [Related]
30. An integrated approach to uncover driver genes in breast cancer methylation genomes.
Shen X; Li S; Zhang L; Li H; Hong G; Zhou X; Zheng T; Zhang W; Hao C; Shi T; Liu C; Guo Z
PLoS One; 2013; 8(4):e61214. PubMed ID: 23579546
[TBL] [Abstract][Full Text] [Related]
31. Integrating multiple omics data for the discovery of potential Beclin-1 interactions in breast cancer.
Chen Y; Wang X; Wang G; Li Z; Wang J; Huang L; Qin Z; Yuan X; Cheng Z; Zhang S; Yin Y; He J
Mol Biosyst; 2017 May; 13(5):991-999. PubMed ID: 28401970
[TBL] [Abstract][Full Text] [Related]
32. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
Zhao Y; Gao Y; Xu X; Zhou J; Wang H
BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
[TBL] [Abstract][Full Text] [Related]
33. MOGAT: A Multi-Omics Integration Framework Using Graph Attention Networks for Cancer Subtype Prediction.
Tanvir RB; Islam MM; Sobhan M; Luo D; Mondal AM
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474033
[TBL] [Abstract][Full Text] [Related]
34. Multi-omics analysis reveals a macrophage-related marker gene signature for prognostic prediction, immune landscape, genomic heterogeneity, and drug choices in prostate cancer.
Zhu W; Wu J; Huang J; Xiao D; Li F; Wu C; Li X; Zeng H; Zheng J; Lai W; Wen X
Front Immunol; 2023; 14():1122670. PubMed ID: 37122696
[TBL] [Abstract][Full Text] [Related]
35. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
[TBL] [Abstract][Full Text] [Related]
36. Omics-Based Investigations of Breast Cancer.
Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
[TBL] [Abstract][Full Text] [Related]
37. Pan-cancer evidence of prognosis, immune infiltration, and immunotherapy efficacy for annexin family using multi-omics data.
Shen C; Zhang S; Zhang Z; Yang S; Zhang Y; Lin Y; Fu C; Li Z; Wu Z; Wang Z; Li Z; Guo J; Li P; Hu H
Funct Integr Genomics; 2023 Jun; 23(3):211. PubMed ID: 37358720
[TBL] [Abstract][Full Text] [Related]
38. Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data.
Lin Y; Zhang W; Cao H; Li G; Du W
Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32759821
[TBL] [Abstract][Full Text] [Related]
39. A deep learning approach based on multi-omics data integration to construct a risk stratification prediction model for skin cutaneous melanoma.
Li W; Huang Q; Peng Y; Pan S; Hu M; Wang P; He Y
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15923-15938. PubMed ID: 37673824
[TBL] [Abstract][Full Text] [Related]
40. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
Li J; Li L; You P; Wei Y; Xu B
Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]